Zydis Patient Compliance Study

Patient Compliance Study: New Data Shows Drug Delivery Has Positive Impact on Patient Compliance

Authors: Steve Hamlen, MBA, Karen MacGregor, PhD, Editor, Drug Development & Delivery

Summary: Patient non-compliance in America is a major medical problem with an estimated cost in excess of $290 billion a year, according to a report from the New England Healthcare Institute. A recent study of longitudinal patient records at Catalent Pharma Solutions supports the theory that drug delivery can improve patient medication compliance. The 1-year study compared the compliance rates of two oral delivery methods for the delivery of selegiline: a standard pill and orally disintegrating tablet (ODT) formulation that achieved pre-gastric absorption. Results showed a 98.5% compliance rate with the ODT formulation compared to 81% with the standard oral treatment in US Medicare patients. Click below to download a copy of the entire article.

DOWNLOAD PDF